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Abstract 
A novel PDGF aptasensor is proposed in this study based on gold nanoparticles (NPs) triggered chemiluminescence 
(CL) upon target binding. The strategy chiefly depends on the formation of a sandwich-type immunocomplex among 
the capture antibody immobilized on the 96-well plate, target protein and aptamer-functionalized gold NPs. 
Introduction of target protein into the assay system leads to the attachment of gold NPs onto the surface of the plates 
and thus the assembled gold NPs could trigger the reaction between luminol and AgNO3 with a CL emission. Further 
signal amplification was achieved by a simple gold metal catalytic deposition onto the gold NPs. This new CL 
strategy might create a novel technology for developing simple aptasensors in the sensitive and selective detection of 
target protein in a variety of clinical, environmental and biodefense applications. 
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1.  Introduction 
With the increasing application of proteomic strategies for cancer diagnosis and disease studies, the 
detection of cancer-related proteins, attracts increasing attention in the biomedical fields. In most 
diagnosis applications, specific molecular recognition of proteins is often accomplished by antibodies. 
Aptamers, the synthetic DNA/RNA oligonucleotides isolated for their ability to selectively bind to 
various biomolecules, have many attractive features including low molecular weight, simple and 
reproducible synthesis, high binding affinity and molecular specificity, straightforward modification, 
tunable binding affinity, and long-term stability [2, 3]. These features make aptamers ideal candidates in 
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biosensing applications. On the basis of aptamers, many aptasensors for proteins have been developed 
with mechanical, optical, or electronic readouts because the detection and quantification of proteins play 
essential roles in fundamental research and clinical applications [4]. In addition, metal nanoparticles offer 
excellent prospects for chemical and biological sensing due to their unique optical and mechanical 
properties. Colloidal gold NPs, which can be readily prepared in a wide range of sizes (from about 2 nm 
to above 100 nm), as an amplification tag, have been the subject of research directed at gene analysis and 
antibody or antigen detection.  
In this study, an aptamer-based sandwich assay in combination with gold NPs amplification was used to 
detect platelet-derived growth factor B-chain (PDGF-BB) that is known to be related to tumor growth and 
transformation. We used a mixture of HAuCl4 and NH2OH, instead of silver staining solution, to enlarge 
gold NPs immobilized on the 96-well plate, based on the seeding method for the detection of PDGF-BB 
using luminol-AgNO3 CL assay (Scheme 1). 
 
 
Scheme 1. Schematic representation of ultrasensitive detection of PDGF-BB by gold nanoparticle triggered chemiluminescence. 
 
2. Experimental 
2.1 Preparation of aptamer-functionlized gold NPs and anti-PDGF modified plates 
Aptamer-functionlized gold NPs and anti-PDGF modified plates were fabricated as follows: 
x Aptamer DNA-functionalized gold NPs were obtained by adding 30 ȝL 40 nm streptavidin gold NPs 
into PBS (8 mM Na2HPO4, 2 mM NaH2PO4, pH 7.4, 0.9 % NaCl) solution that contained 30 pmol 
biotinylated aptamer DNA. The mixture was incubated at 37 oC for 1 h. The conjugates were washed 
three times with 200 ȝL PBS-TW wash buffer (8 mM Na2HPO4, 2 mM NaH2PO4, pH 7.4, 0.9% NaCl, 
0.05% Tween 20) by centrifuging at 12000 rpm for 3 min. The sediment of aptamer-functionlized gold 
NPs was then resuspended in 100 ȝL PBS containing 1% BSA at 4 oC before use. 
x Anti-PDGF modified 96-well plates were obtained by the following steps. First, 300 ng anti-human 
PDGF was dissolved to 300 ng per 100 ȝL in coupling buffer (0.5 M Na2HPO4-NaH2PO4, pH 8.5), 
added into the wells of a DNA-BIND 96-well plate (100 ȝL per well) and then incubated at 37 oC for 1 
h. Second, the wells were washed three times with the wash buffer and then blocked with 3% BSA. 
2.2 Detection of PDGF by CL assay 
Different concentrations of PDGF was added into each well of anti-PDGF modified 96-well plates (100 
ȝL per well, in PBS). Following 1 h incubation with gentle mixing at 37 oC, the wells were washed three 
times with wash buffer. Then 10 ȝL of aptamer DNA-functionalized gold NPs were added and incubated 
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in 100 ȝL PBS containing 1% BSA at 37 oC for 1 h. The wells were then washed three times with wash 
buffer before 50 ȝL of 2.5 mM luminol (0.1 M NaOH) was pipetted into the microwells. Finally, 50 ȝL of 
0.3 mM AgNO3 solution was injected and the CL signal was displayed in the Fluoroskan Ascent FL. 
For the amplification assay procedure, gold NPs that assembled on the surface of the 96-well plate were 
catalytically enlarged in the presence of 1 mM NH2OH and 0.1 mM HAuCl4 at 25 oC for 10 min. The 
plates were washed several times with the wash buffer. Finally, 50 ȝL of 2.5 mM luminol (0.1 M NaOH) 
was pipetted into each well of the plates before  50 ȝL of 0.3 mM AgNO3 solution was injected, then the 
CL signal was detected as described above. 
3. Result and Discussion 
3.1. Optimum reaction conditions  
In order to establish optimal conditions for the CL detection of the PDGF, the single factor experiment 
was used to systematically investigate several parameters, including the amounts of anti-PDGF, 
biotinylated aptamer DNA, 40 nm streptavidin gold, luminol and AgNO3.  
x First, different amounts of anti-PDGF (50, 100, 200, 300, 400, 500 ng) were investigated. The 
maximum CL intensity was observed at the amount of 300 ng of anti-PDGF.  
x Then, amounts of aptamer DNA (0.5, 1, 3, 4, 5 pmol) were also studied. CL signal intensity increased 
with increasing concentration of biotinylated aptamer DNA over the range of 0.5 to 3 pmol, and then 
slowly decreased in the range of 3-5 pmol. Thus, 3 pmol of biotinylated aptamer DNA was selected. 
x Third, five concentrations of 40 nm streptavidin gold (11.1, 22.2, 33.3, 44.4, 55.5 pM) were 
investigated, and 30 pM for the optimum amount was obtained. 
x Additionally, the concentrations of luminol and AgNO3 notably affected the CL intensity. By 
investigating the CL intensity at diverse concentrations of luminol (0.1, 0.5, 1, 2.5, 5 nM) and AgNO3 
(0.05, 0.1, 0.2, 0.3, 0.4, 0.5, 1.0 nM), acquired optimum concentrations were 2.5 nM and 0.3 nM, 
respectively. 
By means of the above experiments, the optimum reaction conditions were obtained: anti-PDGF was 
300 ng, aptamer DNA was 3 pmol, 40 nm streptavidin gold was 33.3 pM, luminol and AgNO3 were 2.5 
and 0.3 NM, respectively. 
3.2. Calibration and linearity 
Under the above-optimized experimental conditions, the quantitative behavior of the method was 
assessed by monitoring the dependence of the CL intensity upon the concentration of PDGF. A 
calibration graph in the concentration range of 0.1-1000 pM showed an approximately linear correlation 
(R2 = 0.9883, Fig. 1) between the concentration of PDGF and the CL intensity after enlargement 
(represented by LgI= 0.524 LgC + 1.4995, where I is the CL intensity and C is the concentration of 
PDGF). The detection sensitivity was significantly increased to approximately 100 fM from three times 
the standard deviation corresponding to the blank sample detection. This level is lower by one to 3 orders 
of magnitude than the limits of fluorescent, QCM, and enzyme-electrochemical methods. 
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Fig. 1. Log-Log calibration plot for the PDGF. 
4. Conclusion 
Overall, the method described is simple, rapid, economic, sensitive, specific, and appears well suited for 
the direct detection of proteins in complex, unprocessed clinical samples. It also provides a realistic 
possibility of aptamer-based applications for convenient point-of-care diagnostics and the field 
monitoring of proteins, and these current results suggest a new way in immunoassay. 
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